Clinical Trial

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

Study acronym: PERSIST
Recruiting
View on ClinicalTrials.gov →
Summary
The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-05
notable Trial sites expanded: 0 -> 3 locations 2026-05-05
Trial Details
NCT Number NCT07507422
Lead Sponsor Medtronic
Conditions Chronic Pain, Intractable Pain
Enrollment 970 participants
Start Date 2026-04-17
Primary Completion 2029-06-27 (estimated)
Study Completion 2034-01-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-04